[
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 118,
      "aas": "R"
    },
    "comment": "G118R is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 121,
      "aas": "Y"
    },
    "comment": "F121Y is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 140,
      "aas": "SAC"
    },
    "comment": "G140S is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN143CR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 143,
      "aas": "CR"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 147,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic HIV-1-associated drug-resistance mutation that has also been reported in INSTI-experienced persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 148,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are nonpolymorphic HIV-1 associated drug-resistance mutation which are also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN153G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 153,
      "aas": "G"
    },
    "comment": "S153YF are extremely rare nonpolymorphic HIV-1-associated INSTI-resistance mutations. A153G is a nonpolymorphic HIV-2 mutation that is selected by INSTIs usually in combination with N155H"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 155,
      "aas": "H"
    },
    "comment": "N155H is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also commonly selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN231_",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 231,
      "aas": "_"
    },
    "comment": "Among HIV-2 isolates, amino  acid insertions at position 231 are selected by INSTIs and associated with markedly reduced INSTI susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 263,
      "aas": "K"
    },
    "comment": "R263K is a nonpolymorphic HIV-1-associated drug-resistance mutation which has also been reported in HIV-2 infected INSTI-experienced persons. "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 51,
      "aas": "Y"
    },
    "comment": "H51Y is an uncommon HIV-1-associated drug-resistance mutation which has also been selected by INSTIs in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN66AIK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 66,
      "aas": "AIK"
    },
    "comment": "T66AIK are HIV-1-associated drug-resistance mutation which have  not been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN84V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a polymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN92GAQ",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 92,
      "aas": "GAQ"
    },
    "comment": "E92Q is an HIV-1-associated drug resistance mutations which is also commonly selected by INSTIs in HIV-2 infected persons. E92G/A have also been reported in INSTI-experienced HIV-2-infected persons"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2AIN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "IN",
      "pos": 97,
      "aas": "A"
    },
    "comment": "Among HIV-1 isolates, T97A is a minimally polymorphic accessory INSTI-selected mutation. Among HIV-2 isolates, T97A is a nonpolymorphic common INSTI-selected mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR10I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 10,
      "aas": "I"
    },
    "comment": "V10I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 23,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic HIV-1 associated PI-resistance mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 30,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level HIV-1 resistance to NFV."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR33I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 33,
      "aas": "I"
    },
    "comment": "V33I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR45R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 45,
      "aas": "R"
    },
    "comment": "K45R is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 47,
      "aas": "A"
    },
    "comment": "V47A is a non-polymorphic common PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR48VA",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 48,
      "aas": "VA"
    },
    "comment": "G48VA are non-polymorphic PI-selected HIV-2 mutations"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic HIV-2 mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 50,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR53Y",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 53,
      "aas": "Y"
    },
    "comment": "F53Y is a nonpolymorphic PI-selected HIV-2 mutation"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR54L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54,
      "aas": "L"
    },
    "comment": "I54L is a nonpolymorphic PI-selected mutation."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR54M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 54,
      "aas": "M"
    },
    "comment": "I54M is a non-polymorphic common PI-selected mutation.  "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR56V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 56,
      "aas": "V"
    },
    "comment": "T56V is a common nonpolymrophic mutation that occurs significantly more commonly in HIV-2 isolates from PI-treated vs. PI-na\u00efve isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR71I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 71,
      "aas": "I"
    },
    "comment": "V71I is a common polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR73G",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 73,
      "aas": "G"
    },
    "comment": "A73G is a nonpolymorphic mutation that occurs significantly more commonoly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82,
      "aas": "F"
    },
    "comment": "I82F is a non-polymorphic common PI-selected mutations that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR82LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 82,
      "aas": "LM"
    },
    "comment": "I82LM are nonpolymorphic PI-selected HIV-2 mutations."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic PI-selected HIV-2 mutation.  "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR85L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 85,
      "aas": "L"
    },
    "comment": "I85V is a non-polymorphic PI-selected mutation. It has minimal, if any, effects on PI susceptibility."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 88,
      "aas": "D"
    },
    "comment": "N88D is a nonpolymorphic HIV-1-associated PI resistance mutation that has been reported in one PI-treated HIV-2 isolate."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 90,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected HIV-2 mutation. "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR95V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 95,
      "aas": "V"
    },
    "comment": "M95V is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2APR99F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "PR",
      "pos": 99,
      "aas": "F"
    },
    "comment": "L99F is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART111I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 111,
      "aas": "I"
    },
    "comment": "V111I is a common polymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 115,
      "aas": "F"
    },
    "comment": "Y11F is associated with reduced susceptibility to each of the NRTIs"
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 116,
      "aas": "Y"
    },
    "comment": "F116Y is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 151,
      "aas": "M"
    },
    "comment": "Q151M causes high-level resistance to each of the NRTIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 184,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART195N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 195,
      "aas": "N"
    },
    "comment": "D195N is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART210ACDEFGHIKLMPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 210,
      "aas": "ACDEFGHIKLMPQRSTVWY_"
    },
    "comment": "210W is an HIV-1 associated TAM. The HIV-2 consensus at this position is N. Mutations at this position have not been selected by NRTIs in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART214L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 214,
      "aas": "L"
    },
    "comment": "F214L is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART215YF",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 215,
      "aas": "YF"
    },
    "comment": "S215Y/F occur significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but their effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART219ACDFGHIKLMNPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 219,
      "aas": "ACDFGHIKLMNPQRSTVWY_"
    },
    "comment": "219QENR are HIV-1 associated TAMs. The HIV-2 consensus  at this position is E. Mutations at this position have not been selected by NRTIs in HIV-2 isolates. "
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART40R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 40,
      "aas": "R"
    },
    "comment": "K40R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 41,
      "aas": "L"
    },
    "comment": "M41L is an HIV-1 associated TAM that has not been selected by NRTIs in HIV-2-infected persons and has not been associated with reduced HIV-2 susceptibility to NRTIs."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 62,
      "aas": "V"
    },
    "comment": "A62V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART65EN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65,
      "aas": "EN"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to XXX.K65N/E are mutations that have rarely been selected by TDF, ABC, and d4T in HIV-1 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 65,
      "aas": "R"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to XXX."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART67NGESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 67,
      "aas": "NGESTH"
    },
    "comment": "D67 mutations are commonly occurring HIV-1-assocated TAMs that are not selected in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "-"
    },
    "comment": "Deletions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69S",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "S"
    },
    "comment": "N69S is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 69,
      "aas": "_"
    },
    "comment": "Insertions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART70N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70,
      "aas": "N"
    },
    "comment": "K70N occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 70,
      "aas": "R"
    },
    "comment": "K70R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 74,
      "aas": "VI"
    },
    "comment": "L74VI are common HIV-1-associated NRTI-resistance mutations that have not been reported in HIV-2 sequences."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART75V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 75,
      "aas": "V"
    },
    "comment": "I75V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2A",
    "commentName": "HIV2ART77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2A",
      "gene": "RT",
      "pos": 77,
      "aas": "L"
    },
    "comment": "F77L is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN118R",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 118,
      "aas": "R"
    },
    "comment": "G118R is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN121Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 121,
      "aas": "Y"
    },
    "comment": "F121Y is an uncommon HIV-1-associated drug-resistance mutation which has not yet been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN140SAC",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 140,
      "aas": "SAC"
    },
    "comment": "G140S is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN143CR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 143,
      "aas": "CR"
    },
    "comment": "Y143C/R are non-polymorphic mutations associated with high-level RAL resistance. Alone, they have minimal effects on EVG susceptibility. However, they are associated with intermediate to high-level reductions in EVG susceptibility when they occur in combination with one or more accessory INSTI-resistance mutations. Y143 mutations do not reduce DTG or BIC susceptibility."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN147G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 147,
      "aas": "G"
    },
    "comment": "S147G is a non-polymorphic HIV-1-associated drug-resistance mutation that has also been reported in INSTI-experienced persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN148HKR",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 148,
      "aas": "HKR"
    },
    "comment": "Q148H/K/R are nonpolymorphic HIV-1 associated drug-resistance mutation which are also selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN153G",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 153,
      "aas": "G"
    },
    "comment": "S153YF are extremely rare nonpolymorphic HIV-1-associated INSTI-resistance mutations. A153G is a nonpolymorphic HIV-2 mutation that is selected by INSTIs usually in combination with N155H"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN155H",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 155,
      "aas": "H"
    },
    "comment": "N155H is a nonpolymorphic HIV-1 associated drug-resistance mutation which is also commonly selected by INSTIs in HIV-2-infected persons"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN231_",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 231,
      "aas": "_"
    },
    "comment": "Among HIV-2 isolates, amino  acid insertions at position 231 are selected by INSTIs and associated with markedly reduced INSTI susceptibility."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN263K",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 263,
      "aas": "K"
    },
    "comment": "R263K is a nonpolymorphic HIV-1-associated drug-resistance mutation which has also been reported in HIV-2 infected INSTI-experienced persons. "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN51Y",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 51,
      "aas": "Y"
    },
    "comment": "H51Y is an uncommon HIV-1-associated drug-resistance mutation which has also been selected by INSTIs in HIV-2 infected patients."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN66AIK",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 66,
      "aas": "AIK"
    },
    "comment": "T66AIK are HIV-1-associated drug-resistance mutation which have  not been reported in HIV-2 infected patients."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN84V",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a polymorphic HIV-2 associated mutation that occurs significantly more commonly in INSTI-experienced compared with INSTI-na\u00efve persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN92GAQ",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 92,
      "aas": "GAQ"
    },
    "comment": "E92Q is an HIV-1-associated drug resistance mutations which is also commonly selected by INSTIs in HIV-2 infected persons. E92G/A have also been reported in INSTI-experienced HIV-2-infected persons"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BIN97A",
    "drugClass": "INSTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "IN",
      "pos": 97,
      "aas": "A"
    },
    "comment": "Among HIV-1 isolates, T97A is a minimally polymorphic accessory INSTI-selected mutation. Among HIV-2 isolates, T97A is a nonpolymorphic common INSTI-selected mutation."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR10I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 10,
      "aas": "I"
    },
    "comment": "V10I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR23I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 23,
      "aas": "I"
    },
    "comment": "L23I is an uncommon non-polymorphic HIV-1 associated PI-resistance mutation."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR30N",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 30,
      "aas": "N"
    },
    "comment": "D30N is a non-polymorphic mutation that causes high-level HIV-1 resistance to NFV."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR33I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 33,
      "aas": "I"
    },
    "comment": "V33I is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR45R",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 45,
      "aas": "R"
    },
    "comment": "K45R is a minimally polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR47A",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 47,
      "aas": "A"
    },
    "comment": "V47A is a non-polymorphic common PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR48VA",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 48,
      "aas": "VA"
    },
    "comment": "G48VA are non-polymorphic PI-selected HIV-2 mutations"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR50L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 50,
      "aas": "L"
    },
    "comment": "I50L is a non-polymorphic HIV-2 mutation selected by ATV. It causes high-level resistance to ATV and increases susceptibility to most of the remaining PIs."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR50V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 50,
      "aas": "V"
    },
    "comment": "I50V is a non-polymorphic PI-selected mutation that reduces HIV-2 susceptibility to LPV and other PIs.  "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR53Y",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 53,
      "aas": "Y"
    },
    "comment": "F53Y is a nonpolymorphic PI-selected HIV-2 mutation"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR54L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 54,
      "aas": "L"
    },
    "comment": "I54L is a nonpolymorphic PI-selected mutation."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR54M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 54,
      "aas": "M"
    },
    "comment": "I54M is a non-polymorphic common PI-selected mutation.  "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR56V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 56,
      "aas": "V"
    },
    "comment": "T56V is a common nonpolymrophic mutation that occurs significantly more commonly in HIV-2 isolates from PI-treated vs. PI-na\u00efve isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR71I",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 71,
      "aas": "I"
    },
    "comment": "V71I is a common polymorphic mutation that occurs significantly more commonly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR73G",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 73,
      "aas": "G"
    },
    "comment": "A73G is a nonpolymorphic mutation that occurs significantly more commonoly in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR82F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 82,
      "aas": "F"
    },
    "comment": "I82F is a non-polymorphic common PI-selected mutations that reduces HIV-2 susceptibility to LPV and other PIs."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR82LM",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 82,
      "aas": "LM"
    },
    "comment": "I82LM are nonpolymorphic PI-selected HIV-2 mutations."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR84V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 84,
      "aas": "V"
    },
    "comment": "I84V is a non-polymorphic PI-selected HIV-2 mutation.  "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR85L",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 85,
      "aas": "L"
    },
    "comment": "I85V is a non-polymorphic PI-selected mutation. It has minimal, if any, effects on PI susceptibility."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR88D",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 88,
      "aas": "D"
    },
    "comment": "N88D is a nonpolymorphic HIV-1-associated PI resistance mutation that has been reported in one PI-treated HIV-2 isolate."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR90M",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 90,
      "aas": "M"
    },
    "comment": "L90M is a non-polymorphic PI-selected HIV-2 mutation. "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR95V",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 95,
      "aas": "V"
    },
    "comment": "M95V is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BPR99F",
    "drugClass": "PI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "PR",
      "pos": 99,
      "aas": "F"
    },
    "comment": "L99F is a nonpolymorphic mutations that occurs significantly more common in PI-treated than PI-na\u00efve HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT111I",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 111,
      "aas": "I"
    },
    "comment": "V111I is a common polymorphic mutation that occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT115F",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 115,
      "aas": "F"
    },
    "comment": "Y11F is associated with reduced susceptibility to each of the NRTIs"
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT116Y",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 116,
      "aas": "Y"
    },
    "comment": "F116Y is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT151M",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 151,
      "aas": "M"
    },
    "comment": "Q151M causes high-level resistance to each of the NRTIs."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT184VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 184,
      "aas": "VI"
    },
    "comment": "M184V/I cause high-level in vitro resistance to 3TC and FTC and low-level resistance to ABC. However, M184V/I are not contraindications to continued treatment with 3TC or FTC because they increase susceptibility to AZT, TDF and d4T and are associated with clinically significant reductions in HIV-1 replication."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT195N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 195,
      "aas": "N"
    },
    "comment": "D195N is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT210ACDEFGHIKLMPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 210,
      "aas": "ACDEFGHIKLMPQRSTVWY_"
    },
    "comment": "210W is an HIV-1 associated TAM. The HIV-2 consensus at this position is N. Mutations at this position have not been selected by NRTIs in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT214L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 214,
      "aas": "L"
    },
    "comment": "F214L is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT215YF",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 215,
      "aas": "YF"
    },
    "comment": "S215Y/F occur significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but their effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT219ACDFGHIKLMNPQRSTVWY_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 219,
      "aas": "ACDFGHIKLMNPQRSTVWY_"
    },
    "comment": "219QENR are HIV-1 associated TAMs. The HIV-2 consensus  at this position is E. Mutations at this position have not been selected by NRTIs in HIV-2 isolates. "
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT40R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 40,
      "aas": "R"
    },
    "comment": "K40R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT41L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 41,
      "aas": "L"
    },
    "comment": "M41L is an HIV-1 associated TAM that has not been selected by NRTIs in HIV-2-infected persons and has not been associated with reduced HIV-2 susceptibility to NRTIs."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT62V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 62,
      "aas": "V"
    },
    "comment": "A62V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT65EN",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 65,
      "aas": "EN"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to XXX.K65N/E are mutations that have rarely been selected by TDF, ABC, and d4T in HIV-1 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT65R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 65,
      "aas": "R"
    },
    "comment": "K65R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons and is associated with reduced susceptibility to XXX."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT67NGESTH",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 67,
      "aas": "NGESTH"
    },
    "comment": "D67 mutations are commonly occurring HIV-1-assocated TAMs that are not selected in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT69-",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69,
      "aas": "-"
    },
    "comment": "Deletions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT69S",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69,
      "aas": "S"
    },
    "comment": "N69S is a slighly polymorphic HIV-2 mutation that occurs with increased frequency in NRTI-treated persons."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT69_",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 69,
      "aas": "_"
    },
    "comment": "Insertions in the Beta3-Beta4 loop are associated with reduced HIV-1 susceptibility to each of the NRTIs but they have not been reported in HIV-2 isolates."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT70N",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 70,
      "aas": "N"
    },
    "comment": "K70N occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT70R",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 70,
      "aas": "R"
    },
    "comment": "K70R occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT74VI",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 74,
      "aas": "VI"
    },
    "comment": "L74VI are common HIV-1-associated NRTI-resistance mutations that have not been reported in HIV-2 sequences."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT75V",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 75,
      "aas": "V"
    },
    "comment": "I75V occurs significantly more commonly in HIV-2 sequences from NRTI-treated than NRTI-na\u00efve persons but its effects on HIV-2 susceptibility to NRTIs is uncertain."
  },
  {
    "strain": "HIV2B",
    "commentName": "HIV2BRT77L",
    "drugClass": "NRTI",
    "conditionType": "MUTATION",
    "conditionValue": {
      "strain": "HIV2B",
      "gene": "RT",
      "pos": 77,
      "aas": "L"
    },
    "comment": "F77L is an accessory HIV-1-associated mutation that usually occurs in combination with the multi-NRTI resistance mutation Q151M. It has not been associated with NRTI therapy in HIV-2 isolates."
  }
]